Evidence map›Paper›PMID 34206709›Full record

ArticleCancers2021

Correction: Dueñas et al. Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals.

Nuria Dueñas, Matilde Navarro, Àlex Teulé, Ares Solanes, Mònica Salinas, Sílvia Iglesias, Elisabet Munté, Jordi Ponce, Jordi Guardiola, Esther Kreisler and 9 more

Abstract readPublished Erratum
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Nuria DueñasHereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain.ORCID 0000-0001-6624-3265
Matilde NavarroHereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain.
Àlex TeuléHereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain.ORCID 0000-0003-0028-7200
Ares SolanesHereditary Cancer Program, Catalan Institute of Oncology, 08916 Badalona, Barcelona, Spain.
Mònica SalinasHereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain.
Sílvia IglesiasHereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain.
Elisabet MuntéHereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain.
Jordi PonceDepartment of Gynecology, Bellvitge University Hospital, Hospitalet de Llobregat, 08908 Barcelona, Spain.ORCID 0000-0002-0613-2261
Jordi GuardiolaDepartment of Gastroenterology, Bellvitge University Hospital, Hospitalet de Llobregat, 08908 Barcelona, Spain.ORCID 0000-0002-0464-241X
Esther KreislerDepartment of General Surgery, Bellvitge University Hospital, Hospitalet de Llobregat, 08908 Barcelona, Spain.
Elvira CarballasDepartment of Gynecology, Trias i Pujol University Hospital, 08916 Badalona, Barcelona, Spain.
Marta CuadradoDepartment of General Surgery, Trias i Pujol University Hospital, 08916 Badalona, Barcelona, Spain.
Xavier Matias-GuiuDepartment of Pathology, Bellvitge University Hospital, Hospitalet de Llobregat, 08908 Barcelona, Spain.
Napoleón de la OssaDepartment of Pathology, Trias i Pujol University Hospital, 08916 Badalona, Barcelona, Spain.ORCID 0000-0002-5046-8758
Joan LopDepartment of Pathology, Hospital del Mar Institute for Medical Research, 08003 Barcelona, Spain.ORCID 0000-0002-9442-5688
Conxi LázaroHereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain.
Gabriel CapelláHereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain.ORCID 0000-0002-4669-7320
Marta PinedaHereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain.ORCID 0000-0002-5403-5845
Joan BrunetHereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain.ORCID 0000-0003-1945-3512

Funding

Catalan-Balearic Society of Oncology 2018 grant of the Catalan-Balearic Society of OncologyCIBERONC 2017SGR1282Government of Catalonia PERIS SLT002/16/0037instituto de salud carlos III CM19/00099Spanish Ministry of Economy and Competitiveness SAF2015-68016-R
6 · The paper itself

Abstract

In the original article, there was a mistake in Figure 3 as published [...].

Identifiers

PMID34206709
PMCPMC8268357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.